145 related articles for article (PubMed ID: 30548484)
21. Effect of EphA7 Silencing on Proliferation, Invasion and Apoptosis in Human Laryngeal Cancer Cell Lines Hep-2 and AMC-HN-8.
Xiang C; Lv Y; Wei Y; Wei J; Miao S; Mao X; Gu X; Song K; Jia S
Cell Physiol Biochem; 2015; 36(2):435-45. PubMed ID: 25968442
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1.
Shuang Y; Li C; Zhou X; Huang Y; Zhang L
Oncol Rep; 2017 Oct; 38(4):2155-2165. PubMed ID: 28791411
[TBL] [Abstract][Full Text] [Related]
23. Retrospective analysis of 659 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations.
Tang D; Tao L; Zhou L; Zhang M; Wu H; Li X; Chen X; Li C; Xie M; Cheng L
Acta Otolaryngol; 2018 Nov; 138(11):1043-1050. PubMed ID: 30776268
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor mutations in Chinese patients with laryngeal squamous cell carcinoma.
Wang DS; Lai HC; Huang JM
Acta Otolaryngol; 2014 Jun; 134(6):631-5. PubMed ID: 24646139
[TBL] [Abstract][Full Text] [Related]
25. Expression of DCUN1D1 in laryngeal squamous cell carcinoma and its inhibiting effect on TU-177 cells after interfered by RNA.
Liu J; Shuang Y; Li C; Zhou X; Huang Y; Zhang L
Clin Exp Pharmacol Physiol; 2018 May; 45(5):461-466. PubMed ID: 29164666
[TBL] [Abstract][Full Text] [Related]
26. LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.
Shen Z; Lin L; Cao B; Zhou C; Hao W; Ye D
World J Surg Oncol; 2018 Mar; 16(1):42. PubMed ID: 29499699
[TBL] [Abstract][Full Text] [Related]
27. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
[TBL] [Abstract][Full Text] [Related]
28. Postoperative radiotherapy for laryngeal carcinoma: the prognostic role of subcellular Maspin expression.
Lionello M; Blandamura S; Staffieri C; Tealdo G; Giacomelli L; Marchese Ragona R; de Filippis C; Staffieri A; Marioni G
Am J Otolaryngol; 2015; 36(2):184-9. PubMed ID: 25459315
[TBL] [Abstract][Full Text] [Related]
29. Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma.
Mann JE; Smith JD; Birkeland AC; Bellile E; Swiecicki P; Mierzwa M; Chinn SB; Shuman AG; Malloy KM; Casper KA; McLean SA; Moyer JS; Wolf GT; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC
Cancer Immunol Immunother; 2019 Feb; 68(2):213-220. PubMed ID: 30361882
[TBL] [Abstract][Full Text] [Related]
30. Diminished expression of S100A2, a putative tumour suppressor, is an independent predictive factor of neck node relapse in laryngeal squamous cell carcinoma.
Almadori G; Bussu F; Galli J; Rigante M; Lauriola L; Michetti F; Maggiano N; Schafer BW; Heizmann CW; Ranelletti FO; Paludetti G
J Otolaryngol Head Neck Surg; 2009 Feb; 38(1):16-22. PubMed ID: 19344608
[TBL] [Abstract][Full Text] [Related]
31. [The mutation and expression of MUS81 gene in laryngeal squamous cell carcinoma].
Li C; Wang S; Yuan H; Li W; Li Z; Li X; Guo X; Li F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):560-5. PubMed ID: 18841572
[TBL] [Abstract][Full Text] [Related]
32. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
[TBL] [Abstract][Full Text] [Related]
33. Alterations of p53 and Bcl-2 protein expression in the recurrent laryngeal and pharyngeal squamous cell carcinoma.
Rashad UM; Hussein MR; Algizawy SM
Am J Otolaryngol; 2011; 32(3):210-4. PubMed ID: 20434805
[TBL] [Abstract][Full Text] [Related]
34. DIAPH2 alterations increase cellular motility and may contribute to the metastatic potential of laryngeal squamous cell carcinoma.
Kostrzewska-Poczekaj M; Byzia E; Soloch N; Jarmuz-Szymczak M; Janiszewska J; Kowal E; Paczkowska J; Kiwerska K; Wierzbicka M; Bartochowska A; Ustaszewski A; Greczka G; Grenman R; Szyfter K; Giefing M
Carcinogenesis; 2019 Oct; 40(10):1251-1259. PubMed ID: 30793164
[TBL] [Abstract][Full Text] [Related]
35. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
[TBL] [Abstract][Full Text] [Related]
36. The molecular genetics of laryngeal cancer.
Loyo M; Pai SI
Otolaryngol Clin North Am; 2008 Aug; 41(4):657-72, v. PubMed ID: 18570952
[TBL] [Abstract][Full Text] [Related]
37. CD47 is a Potential Target for the Treatment of Laryngeal Squamous Cell Carcinoma.
Yang C; Gao S; Zhang H; Xu L; Liu J; Wang M; Zhang S
Cell Physiol Biochem; 2016; 40(1-2):126-136. PubMed ID: 27855370
[TBL] [Abstract][Full Text] [Related]
38.
Gong XY; Chen HB; Zhang LQ; Chen DS; Li W; Chen DH; Xu J; Zhou H; Zhao LL; Song YJ; Xiao MZ; Deng WL; Qi C; Wang XR; Chen X
Front Immunol; 2022; 13():920253. PubMed ID: 35911687
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
Liu Y; Zhang X; Qiu YZ; Huang DH; Zhou XJ; Tan PQ; Cai GM; Dai YZ; Yu CY; Xiao JY; Tian YQ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):197-201. PubMed ID: 21575519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
